| |
| |
|
| Insider
Information: |
James Steven P |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
X1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -132.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cascadian Therapeutics, Inc |
CASC |
Director |
2018-03-09 |
0 |
2017-03-12 |
0 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
Director |
2017-12-11 |
0 |
2017-06-20 |
0 |
Premium* |
|
|
Allakos Inc. |
ALLK |
Director |
2021-09-28 |
0 |
2021-03-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALLK |
Allakos Inc. |
Director |
– • – |
2021-09-28 |
4 |
S |
$108.12 |
$432,480 |
D/D |
(4,000) |
0 |
0 |
% |
|
| ALLK |
Allakos Inc. |
Director |
– • – |
2021-09-28 |
4 |
OE |
$0.53 |
$2,100 |
D/D |
4,000 |
4,000 |
0 |
- |
|
| ALLK |
Allakos Inc. |
Director |
– • – |
2021-03-16 |
4 |
OE |
$0.53 |
$1,838 |
D/D |
3,500 |
3,500 |
0 |
- |
|
| ALLK |
Allakos Inc. |
Director |
– • – |
2021-03-16 |
4 |
S |
$121.65 |
$425,775 |
D/D |
(3,500) |
0 |
0 |
% |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2018-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,677) |
0 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2017-12-11 |
4 |
D |
$1.52 |
$19,000 |
D/D |
(12,500) |
0 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2017-09-24 |
4 |
D |
$3.94 |
$2,340 |
D/D |
(594) |
13,677 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2017-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,375 |
14,271 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2017-06-24 |
4 |
D |
$3.78 |
$8,562 |
D/D |
(2,265) |
11,896 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2017-06-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,058 |
14,161 |
0 |
- |
|
| OCRX |
Ocera Therapeutics Inc |
Director |
– • – |
2017-06-20 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
12,500 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2017-06-12 |
4 |
D |
$3.34 |
$1,794 |
D/D |
(537) |
5,103 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2017-06-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,148 |
5,640 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2017-03-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,656 |
4,656 |
0 |
- |
|
| CASC |
Cascadian Therapeutics, I... |
Director |
– • – |
2017-03-12 |
4 |
D |
$4.35 |
$5,063 |
D/D |
(1,164) |
3,492 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
